Spécialisé en chirurgie laparoscopique avancée et oncologique – Muzaffer Al a suivi une formation approfondie dans des institutions médicales de premier plan.
Spécialiste de la chirurgie du cancer de la thyroïde aux hôpitaux Büyük Anadolu, avec une expertise dans plusieurs domaines de l'oncologie chirurgicale.
Éducation
Expérience
Professeur d'oncologie médicale avec plus de 15 ans d'expérience dévouée à l'hôpital Florence Nightingale de Gayrettepe.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
| Médecin | expérience | Bon choix pour | Ce qui les distingue | Clinique et emplacement | Consultation |
|---|---|---|---|---|---|
| 16 années d'expérience | Chirurgie thyroïdienne mini-invasive | Spécialisation en chirurgie laparoscopique avancée et oncologique – formation au sein d'institutions de premier plan, notamment l'Université d'Istanbul. | Turquie | Prix sur demande | |
| 11 années d'expérience | Chirurgie du cancer de la thyroïde | Spécialisé dans le cancer de la thyroïde ainsi que dans d'autres chirurgies oncologiques. Travaille aux hôpitaux Büyük Anadolu avec une large expertise en oncologie chirurgicale. | Turquie | Prix sur demande | |
| 31 années d'expérience | Cas d'oncologie radiothérapique | Spécialisation en radiothérapie pour le cancer de la thyroïde, avec des fonctions de direction académique et une formation approfondie aux techniques avancées de radio-oncologie. | Turquie | Prix sur demande | |
| 29 années d'expérience | Cas d'oncologie gastro-intestinale | Spécialisé en oncologie gastro-intestinale — chose rare parmi les spécialistes du cancer de la thyroïde. Professeur, membre actif des sociétés d'oncologie ESMO et ASCO. | Turquie | de $300 |